title: A novel G protein-coupled receptor of Schistosoma mansoni (SmGPR-3) is activated by dopamine and is widely expressed in the nervous system.
abstract: Schistosomes have a well developed nervous system that coordinates virtually every activity of the parasite and therefore is considered to be a promising target for chemotherapeutic intervention. Neurotransmitter receptors, in particular those involved in neuromuscular control, are proven drug targets in other helminths but very few of these receptors have been identified in schistosomes and little is known about their roles in the biology of the worm. Here we describe a novel Schistosoma mansoni G protein-coupled receptor (named SmGPR-3) that was cloned, expressed heterologously and shown to be activated by dopamine, a well established neurotransmitter of the schistosome nervous system. SmGPR-3 belongs to a new clade of "orphan" amine-like receptors that exist in schistosomes but not the mammalian host. Further analysis of the recombinant protein showed that SmGPR-3 can also be activated by other catecholamines, including the dopamine metabolite, epinine, and it has an unusual antagonist profile when compared to mammalian receptors. Confocal immunofluorescence experiments using a specific peptide antibody showed that SmGPR-3 is abundantly expressed in the nervous system of schistosomes, particularly in the main nerve cords and the peripheral innervation of the body wall muscles. In addition, we show that dopamine, epinine and other dopaminergic agents have strong effects on the motility of larval schistosomes in culture. Together, the results suggest that SmGPR-3 is an important neuronal receptor and is probably involved in the control of motor activity in schistosomes. We have conducted a first analysis of the structure of SmGPR-3 by means of homology modeling and virtual ligand-docking simulations. This investigation has identified potentially important differences between SmGPR-3 and host dopamine receptors that could be exploited to develop new, parasite-selective anti-schistosomal drugs.
authors.affiliation: Institute of Parasitology, McGill University, Sainte Anne de Bellevue, Quebec, Canada.
authors.forename: Fouad
authors.initials: F
authors.lastname: El-Shehabi
authors.forename: Amira
authors.initials: A
authors.lastname: Taman
authors.forename: Lorena S
authors.initials: LS
authors.lastname: Moali
authors.forename: Nelly
authors.initials: N
authors.lastname: El-Sakkary
authors.forename: Paula
authors.initials: P
authors.lastname: Ribeiro
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D003001:Cloning, Molecular; D003846:Deoxyepinephrine / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism*; D015870:Gene Expression; D008124:Locomotion / Q000187:drug effects; D008969:Molecular Sequence Data; D009420:Nervous System / Q000378:metabolism*; D043562:Receptors, G-Protein-Coupled / Q000819:agonists* / Q000037:antagonists & inhibitors / Q000235:genetics*; D012550:Schistosoma mansoni / Q000235:genetics* / Q000378:metabolism* / Q000502:physiology; D017386:Sequence Homology, Amino Acid
chemical_list: D043562:Receptors, G-Protein-Coupled; D003846:Deoxyepinephrine; D004298:Dopamine